These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4949233)

  • 1. An appraisal of the mechanism of action of the sulphonylurea drugs.
    Martin FI
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:31-6. PubMed ID: 4949233
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
    Poltorak VV; Gladkikh AI
    Probl Endokrinol (Mosk); 1985; 31(2):76-85. PubMed ID: 2859589
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide.
    Artini D; Abbiati R; Orsini G; Parenti MA; Bloch K; Daturi S; Mandelli V
    Diabetologia; 1973 Sep; ():311-6. PubMed ID: 4204091
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypoglycemic effect of glipizide. Study in 20 diabetic patients with low pancreatic insulin reserve].
    Laviada E; Camara M
    Prensa Med Mex; 1973; 38(7):297-302. PubMed ID: 4596814
    [No Abstract]   [Full Text] [Related]  

  • 5. [The present status of the question of the mechanism of action of sulfanilamide hypoglycemic preparations and several aspects of their use in the treatment of diabetes mellitus].
    Mordkovskaia NM
    Probl Endokrinol (Mosk); 1971; 17(5):121-5. PubMed ID: 4337075
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mode of action of oral hypoglycemic sulfonylureas].
    Paes E
    Rev Iber Endocrinol; 1972; 19(113):449-59. PubMed ID: 4563178
    [No Abstract]   [Full Text] [Related]  

  • 7. [Secretion of insulin under the influence of sulfonylurea derivates (SH)].
    Rothenbuchner G; Raptis S; Pfeiffer EF
    Wien Z Inn Med; 1973; 54(2):69-77. PubMed ID: 4203274
    [No Abstract]   [Full Text] [Related]  

  • 8. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
    Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
    [No Abstract]   [Full Text] [Related]  

  • 9. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
    Marble A
    Drugs; 1971; 1(2):109-15. PubMed ID: 4999930
    [No Abstract]   [Full Text] [Related]  

  • 10. Sulfonylureas: background and development of the field.
    Levine R
    Diabetes Care; 1984; 7 Suppl 1():3-7. PubMed ID: 6376027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulinotropic action of a new sulfonylurea: gliclazide.
    Malaisse WJ; Leclercq-Meyer V
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):310-4. PubMed ID: 4626523
    [No Abstract]   [Full Text] [Related]  

  • 12. [Molecular mechanism of action of sulfonylureas].
    Ammon HP
    Dtsch Med Wochenschr; 1988 May; 113(21):864-70. PubMed ID: 3286184
    [No Abstract]   [Full Text] [Related]  

  • 13. Sulfonylurea drugs: mechanism of antidiabetic action and therapeutic usefulness.
    Lebovitz HE; Feinglos MN
    Diabetes Care; 1978; 1(3):189-98. PubMed ID: 365478
    [No Abstract]   [Full Text] [Related]  

  • 14. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo (b) furan-7-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). II. Pharmacological studies on the mechanism of action.
    Jorgensen KD
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):227-33. PubMed ID: 190857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extrapancreatic effects of oral sulfonylureas].
    Beyer J; Cordes U; Krall H; Rosak C; Schöffling K
    Verh Dtsch Ges Inn Med; 1971; 77():539-43. PubMed ID: 5155894
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic effects of sulfonylurea drugs. A review.
    Groop L
    Ann Clin Res; 1983; 15 Suppl 37():16-20. PubMed ID: 6148037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus.
    DeFronzo RA; Ferrannini E; Koivisto V
    Am J Med; 1983 Jan; 74(1A):52-81. PubMed ID: 6337486
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.
    Pfeifer MA; Halter JB; Judzewitsch RG; Beard JC; Best JD; Ward WK; Porte D
    Diabetes Care; 1984; 7 Suppl 1():25-34. PubMed ID: 6376026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs].
    Loubatières AL; Ribes G; Loubatières-Mariani MM
    C R Seances Soc Biol Fil; 1972; 166(8):1047-50. PubMed ID: 4573746
    [No Abstract]   [Full Text] [Related]  

  • 20. [Glipizide a new oral antidiabetic agent (comprehensive review)].
    Brunová E
    Vnitr Lek; 1976 Jun; 22(6):595-9. PubMed ID: 820071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.